1-[[2-(2,2-difluoroethyl)-1,2,4-triazol-3-yl]methyl]-1-methyl-3-[(2S)-2-(5-methyl-1,3-thiazol-2-yl)propyl]urea
C14H20F2N6OS — CID 100702959
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[[2-(2,2-difluoroethyl)-1,2,4-triazol-3-yl]methyl]-1-methyl-3-[(2S)-2-(5-methyl-1,3-thiazol-2-yl)propyl]urea
1-[[2-(2,2-difluoroethyl)-1,2,4-triazol-3-yl]methyl]-1-methyl-3-[(2S)-2-(5-methyl-1,3-thiazol-2-yl)propyl]urea (PubChem CID 100702959) has the molecular formula C14H20F2N6OS and a molecular weight of 358.42 g/mol. Its IUPAC name is 1-[[2-(2,2-difluoroethyl)-1,2,4-triazol-3-yl]methyl]-1-methyl-3-[(2S)-2-(5-methyl-1,3-thiazol-2-yl)propyl]urea.
Molecular Properties
| Compound Name | 1-[[2-(2,2-difluoroethyl)-1,2,4-triazol-3-yl]methyl]-1-methyl-3-[(2S)-2-(5-methyl-1,3-thiazol-2-yl)propyl]urea |
|---|---|
| PubChem CID | 100702959 |
| Molecular Formula | C14H20F2N6OS |
| Molecular Weight | 358.42 g/mol |
| Exact Mass | 358.14 |
| IUPAC Name | 1-[[2-(2,2-difluoroethyl)-1,2,4-triazol-3-yl]methyl]-1-methyl-3-[(2S)-2-(5-methyl-1,3-thiazol-2-yl)propyl]urea |
| SMILES | Cc1cnc([C@@H](C)CNC(=O)N(C)Cc2ncnn2CC(F)F)s1 |
| InChI | InChI=1S/C14H20F2N6OS/c1-9(13-17-5-10(2)24-13)4-18-14(23)21(3)7-12-19-8-20-22(12)6-11(15)16/h5,8-9,11H,4,6-7H2,1-3H3,(H,18,23)/t9-/m0/s1 |
| InChIKey | UBJBSMFLYMATOT-VIFPVBQESA-N |
| XLogP | 2.25 |
| TPSA | 75.94 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 358.42 |
| LogP ≤ 5 | 2.25 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 100702959 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.